Gender specificity improves the early-stage detection of clear cell renal cell carcinoma based on methylomic biomarkers.
The two genders are different ranging from the molecular to the phenotypic levels. But most studies did not use this important information. We hypothesize that the integration of gender information may improve the overall prediction accuracy. A comprehensive comparative study was carried out to test the hypothesis. The classification of the stages I + II versus III + IV of the clear cell renal cell carcinoma samples was formulated as an example. In most cases, female-specific model significantly outperformed both-gender model, as similarly for the male-specific model. Our data suggested that gender information is essential for building biomedical classification models and even a simple strategy of building two gender-specific models may outperform the gender-mixed model.